Bowel (colorectal) cancer

This study is looking at people’s experiences of care after cancer treatment.

This study looked at a blood test called a multi cancer early detection (MCED) test. It is also called the Galleri test.

This trial is comparing lenvatinib and pembrolizumab with standard treatment for bowel cancer that has spread (advanced bowel cancer).

This trial is looking at defactinib with VS-6766 for solid cancers. A solid cancer is any cancer apart from leukaemia, lymphoma and myeloma.

This trial is comparing the standard dose of radiotherapy with a higher dose for small cancers of the back passage (rectum).

This study is combining PDR001 with other drugs for cancer that has spread to the nearby tissue (locally advanced) or to another part of the body (metastatic).

This trial is looking at adding other treatments to chemotherapy for bowel cancer that has spread elsewhere in the body.

This trial is looking at fish oil in people having surgery to remove bowel cancer spread to the liver.

This trial looked at having enadenotucirev with chemoradiotherapy for people with cancer of the back passage (rectal cancer) that is locally advanced.